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Pyocardial Contrast Echocardiography Evolving
s a Clinically Feasible Technique for Accurate,
apid, and Safe Assessment of Myocardial Perfusion
he Evidence So Far
ieter A. Dijkmans, MD,* Roxy Senior, MD, PHD,† Harald Becher, MD, PHD,‡
homas R. Porter, MD, PHD,§ Kevin Wei, MD, Cees A. Visser, MD, PHD,* Otto Kamp, MD, PHD*
msterdam, the Netherlands; Harrow and Oxford, United Kingdom; Omaha, Nebraska; and Portland, Oregon
Intravenous myocardial contrast echocardiography (MCE) is a recently developed technique
for assessment of myocardial perfusion. Up to now, many studies have demonstrated that the
sensitivity and specificity of qualitative assessment of myocardial perfusion by MCE in
patients with acute and chronic ischemic heart disease are comparable with other techniques
such as cardiac scintigraphy and dobutamine stress echocardiography. Furthermore, quanti-
tative parameters of myocardial perfusion derived from MCE correlate well with the current
clinical standard for this purpose, positron emission tomography. Myocardial contrast
echocardiography provides a promising and valuable tool for assessment of myocardial
perfusion. Although MCE has been primarily performed for medical research, its implemen-
tation in routine clinical care is evolving. This article is intended to give an overview of the
current status of MCE. (J Am Coll Cardiol 2006;48:2168–77) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.079College of Cardiology Foundation
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phe use of ultrasound contrast agents for left ventricular
pacification and myocardial perfusion in echocardiography
as significantly improved the diagnostic accuracy of stress
chocardiography. In the last decade, the clinical value of
ntravenous myocardial contrast echocardiography (MCE)
n patients with both acute and chronic ischemic heart
isease has been demonstrated. At the same time, experi-
ental and clinical studies have demonstrated the physio-
ogic basis for quantification of myocardial perfusion with
CE. In comparison with other imaging techniques, MCE
s a rapid, easy-to-perform, and safe bedside technique for
he assessment of myocardial perfusion. This article pro-
ides a review of the current status of MCE with respect to
linical value, practical issues, and conditions that need to be
ulfilled for clinical implementation.
CE PROTOCOLS
ltrasound contrast agents. Since 1968, when the exis-
ence of ultrasound contrast was established, the develop-
ent of ultrasound contrast agents has undergone signifi-
ant advances. Initially, contrast agents were air-filled
icrobubbles, that were relatively unstable in the blood and
ould not pass the pulmonary capillary bed, rendering them
nsuitable for the assessment of the left side of the heart
uring intravenous injection. Second-generation contrast
From the *Department of Cardiology, VU University Medical Center, Amsterdam,
he Netherlands; †Department of Cardiovascular Medicine, Northwick Park Hospi-
al, Harrow, United Kingdom; ‡Department of Cardiology, John Radcliffe Hospital,
eadington, Oxford, United Kingdom; §Section of Cardiology, Department of
nternal Medicine, University of Nebraska Medical Center, Omaha, Nebraska; and
he Oregon Health and Science University, Portland, Oregon.r
Manuscript received February 28, 2006; revised manuscript received April 21,
006, accepted May 15, 2006.gents were developed for this reason, containing a gas with
ow solubility and diffusibility and a shell of lipids, albumin,
r galactose to prolong their life span. The microbubbles
ave a diameter less than that of a red blood cell, resist
rterial pressure, and remain intravascular in the intact
irculation. These properties allow passage of the pulmonary
asculature, opacification of the left ventricular cavity, and
maging of myocardial perfusion. Currently, the most used
econd-generation contrast agents are Sonovue (Bracco,
ilan, Italy), Optison (Amersham Health AS, Oslo, Nor-
ay), and Definity (Bristol-Myers Squibb, Billerica, Mas-
achusetts). These agents are licensed for left ventricular
pacification only. These agents differ in terms of their shell
onstituents and gas content, that influence shell-stiffness
nd stability of the microbubble, and determine physical
roperties. All are suitable for MCE.
hysical principles. The mechanism by which micro-
ubbles enhance echocardiographic images, depends on
heir behavior under acoustic pressure. Low-energy ultra-
ound causes microbubbles to oscillate linearly, reflecting
ltrasound at the insonation (fundamental or f0) frequency.
ltrasound with an intermediate energy level induces non-
inear oscillations of microbubbles, resulting in generation
f frequencies other than the fundamental frequency (mul-
iples of the fundamental frequency) which are called
armonic frequencies (e.g., 2f0). Finally, high-intensity
ltrasound (within the energy levels used for diagnostic
maging) destroys microbubbles. In contrast to micro-
ubbles, cardiac tissue produces much fewer harmonic
requencies, so selective reception of harmonic echos will
referentially detect signals emanating from contrast agent
ather than the myocardium.
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December 5, 2006:2168–77 Contrast Echocardiography for Perfusion Imagingmaging modalities. Initial contrast imaging modalities
elied mainly on harmonic imaging techniques, where fun-
amental frequencies were eliminated and harmonic fre-
uencies were selectively detected. Although these methods
mproved the signal-to-noise ratio, off-line image process-
ng was frequently required to evaluate myocardial perfu-
ion, because tissue signals were still present. Harmonic
maging also used high acoustic powers that destroyed
icrobubbles—consequently, the imaging frame rate had to
e reduced substantially with electrocardiographic trigger-
ng to allow microbubbles to replenish the myocardial
icrocirculation between pulses. Recently, several novel
pproaches to imaging microbubbles were developed: These
nclude high-power modalities with superior tissue noise
uppression that allow on-line assessment of myocardial
erfusion and low-power modalities that permit imaging
ith high frame rates. These modalities specifically take
dvantage of the nonlinear behavior of microbubbles in an
coustic field. Many techniques use multiple transmitted
ulses that are, e.g., full and half amplitude (power modu-
ation (Fig. 1) to distinguish nonlinear microbubble signals
rom tissue (1). Reflected echos are scaled and subtracted.
ecause tissue responds linearly (especially at low acoustic
owers), subtraction and scaling results in zero signal.
icrobubbles reflect nonlinearly, so received echos will not
e canceled out, enabling selective microbubble detection.
ost of these multipulse techniques additionally use power
oppler, and the resulting signal is color coded and dis-
layed (2).
Because high-power imaging destroys microbubbles, im-
ging of myocardial perfusion cannot be performed in real
ime. Low-power imaging (mechanical index 0.2) in-
reases signal-to-noise ratio and because of minimal bubble
estruction continuous imaging may be performed. Both
igh- and low-power MCE have their advantages and
isadvantages. High-power imaging precludes continuous
maging owing to destruction of contrast, and therefore wall
otion cannot be assessed simultaneously. On the other
and, signal-to-noise ratio is good. Low-power imaging
llows simultaneous assessment of perfusion and contraction
ut has a lower sensitivity for the detection of microbubbles.
tress agent. The most commonly used stress agents are
denosine, dipyridamole, and dobutamine. All 3 agents have
een used widely for pharmacologic stress during MCE.
Abbreviations and Acronyms
ACS  acute coronary syndrome
AMI  acute myocardial infarction
CAD  coronary artery disease
DSE  dobutamine stress echocardiography
MBF  myocardial blood flow
MBV  myocardial blood volume
MCE  myocardial contrast echocardiography
VI  video intensitylthough the working mechanism of these agents differ, all mgents have a high diagnostic value for detection of coronary
rtery disease (CAD) (Tables 1 and 2).
SSESSMENT OF MYOCARDIAL PERFUSION
ualitative assessment. During continuous infusion of
icrobubbles in a patient with intact coronary microvascu-
ature and normal myocardial blood flow (MBF), destruc-
ion of microbubbles in the microcirculation by ultrasound
s followed by relatively uniform contrast appearance in the
oronary microcirculation, and homogenous opacification of
he myocardium. In case of diminished epicardial flow, e.g.,
n significant CAD during stress, or after AMI, when
icrovascular integrity is affected, the speed and amount of
ontrast replenishment will be decreased. Earliest studies
ssessing MCE mainly used qualitative analysis in which
ontrast replenishment after microbubble destruction was
cored as normal, reduced, or severely reduced. With such a
coring system, irreversible and reversible contrast defects in
atients with flow-limiting CAD could be detected. Also,
n patients with acute coronary syndrome (ACS), these
coring systems have proven their value in determining
nfarct size, viability, and prediction of functional recovery.
uantitative assessment. Because the microvascular rhe-
logy of microbubbles is similar to that of red blood cells,
ssessment of the transit of microbubbles through the
oronary microcirculation with MCE should allow quanti-
cation of MBF (3). The first in vivo studies assessing
uantification of MBF with MCE used bolus injections of
igure 1. Pulse cancellation techniques: principles of power modulation.
A) Resulting signal of tissue reflection. (B) Resulting signal of contrast
eflection.icrobubbles (4–6). The ratio of video intensity (VI) in
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Contrast Echocardiography for Perfusion Imaging December 5, 2006:2168–77iseased/nondiseased vascular territories correlated well
ith radiolabeled microsphere-derived blood flow ratios.
he use of bolus injections of microbubbles, however,
llows assessment of only relative differences in MBF and
ot absolute MBF. This limitation was overcome with
ontinuous microbubble infusions, which allow a steady-
tate microbubble concentration to be reached in the blood.
t this time, after microbubbles are destroyed by ultra-
ound, the subsequent replenishment of microbubbles into
he ultrasound beam elevation will reflect MBF. The re-
lenishment of contrast can be characterized by a time-
ntensity curve (Figs. 2 and 3), which can be fitted to a
onoexponential function: y  A(1  et). The reappear-
nce rate of microbubbles, reflected by the slope of the
eplenishment curve (), provides a measure of mean
yocardial microbubble velocity, and the plateau value (A)
f the replenishment curve reflects the microvascular cross-
ectional area (7). The product of A and  therefore
epresents MBF. Animal studies using a coronary stenosis
odel demonstrated that the MCE estimate of MBF
orrelates very well with absolute MBF as measured with
adiolabeled fluorescent microspheres (8–10). During phar-
able 1. Concordance of MCE and SPECT for Detection of Sig
oronary Artery Disease
Patients (n) Imaging Mode
aul et al. (17) 30 THI
einle et al. (26) 123 HPD
himoni et al. (18) 101 AII
ei et al. (23) 54 HPD
occhi et al. (21) 25 HPD
lszowska et al. (19) 44 HPD
enior et al. (22) 55 IPI
ie et al. (31) 36 RTI
orosoglou et al. (27) 120 PPI
ote: values expressed as concordance and agreement (kappa).
AII  accelerated intermittent imaging; HPD  harmonic power Doppler; IPI 
ulse inversion; RTI  real-time imaging; SPECT  single-photon emission comp
able 2. Sensitivity and Specificity of MCE and SPECT/DSE to
ngiography
Patients
(n)
Definition
Stenosis
Imaging
Mode S
himoni et al. (18) 44 50% AII
lszowska et al. (19)* 44 60% RTHI
occhi et al. (21)* 25 70% HPD
lhendy et al. (29)† 169 50% RTPI
enior et al. (22) 55 50% IPI
eltier et al. (24) 35 70% PM
sutsui et al. (28)* 16 50% RTI
ie et al. (31)† 27 50% PPI
eetley et al. (30) 123 50% TRI
orosoglou et al. (27) 89 75% PPI
aravidas et al. (in press) 47 50% TPD
ooled estimate 85% (
he pooled estimate is a percentage (95% confidence interval). *Analysis by territory
DSE dobutamine stress echocardiography; PM power modulation; RTHI real-tim
oppler; TRI  triggered replenishment imaging; other abbreviations as in Table 1.acologic stress, impaired hyperemic flow in the presence
f coronary stenosis was associated with decreases in both A
nd . Thus, abnormalities in either MBF velocity or MBV
uring stress can be used to detect and quantify stenosis
everity. In dogs, quantification by triggered MCE appeared
o be accurate enough to make a distinction between endo-
nd epicardial flow (11). In humans, similar results were
ound (12). Myocardial blood flow reserve decreased in a
tep-wise manner in mild, moderate, and severe stenosis.
uantitative measures of MCE can not only be used to
stimate stenosis severity, they can also be used to assess
erfusion defect after AMI or to predict recovery of hiber-
ating myocardium (13,14).
Absolute MBF in ml/min/g of tissue can be derived using
CE (14). Vogel et al. (15) have shown that myocardial
lood volume (MBV) fraction can be derived from the ratio
f myocardial video intensity and that of the adjacent left
entricular cavity. This method adjusts for inhomoge-
eous contrast enhancement of the myocardium due to
echnical factors such as attenuation. The MBV fraction
an then be used to derive absolute MBF (MBF 
elative blood volume  /tissue density, where the
ant Coronary Artery Stenosis in Patients With Suspected
Concordance, % (Kappa)
Patient Basis Territory Basis Segment Basis
86 (0.71) 90 (0.77) 92 (0.99)
81 (0.60) 76 (UN) 70 (0.32)
76 (0.50) 76–89 (UN) 92 (0.32)
84 (0.63) 65 (0.41) UN
84 (0.67) 92 (0.81) UN
UN 73–91 (0.4–0.8) 89 (0.81)
UN 70 (0.37) UN
75 (0.50) 85 (0.61) UN
UN 83 (0.65) 86 (0.65)
ittent pulse inversion; MCE  myocardial contrast echocardiography; PPI  power
d tomography; THI  triggered harmonic imaging; UN  unknown.
tect Stable Coronary Artery Disease: Gold Standard
MCE SPECT/DSE
ivity Specificity Sensitivity Specificity
100% 75% 81%
93% 93% 84%
100% 100% 88%
51% 70% 74%
58% 49% 92%
69% 82% 85%
92% 68% 61%
65% 33% 72%
56% 82% 52%
93% 77% 52%
92% 73% 72%
–88.5%) 74% (67.7%–80.3%) 71% (66%–76%) 71% (64%–78%)
ded from meta-analysis. †Compared with DSE.nificDe
ensit
75%
97%
89%
91%
83%
86%
64%
66%
84%
84%
91%
81.5%
, exclu
e harmonic imaging; RTPI real-time perfusion imaging; TPD triggered power
r
s
p
c
p
(
o
m
(
p
M
C
I
b
c
t
m
i
t
fl
v
i
f
b
M
i
d
d
b
s
c
a
s
s
d
o
f
g
M
S
3
t
d
(
s
M
S
p
w
w
i
p
F y (su
a ontra
2171JACC Vol. 48, No. 11, 2006 Dijkmans et al.
December 5, 2006:2168–77 Contrast Echocardiography for Perfusion Imagingelative blood volume is Amyocardium/Acavity). In that
tudy, MCE-derived absolute MBF was compared with
ositron emission tomography and showed excellent
orrelations.
A new application of quantitative MCE is generation of
arametric images derived from contrast-enhanced images
16). These images contain information about the quality
f acquisition, the maximal intensity of contrast in the
yocardium, and the speed of contrast replenishment
Fig. 4) and allows fast visual interpretation of myocardial
erfusion.
CE IN DETECTING STABLE
ORONARY ARTERY DISEASE
n normally perfused myocardium, the rate of capillary
lood flow is 1 mm/s. Saturation of the coronary microvas-
ulature by microbubbles therefore takes about 5 s (because
he thickness of the ultrasound beam is approximately 5
m). When there is no flow limiting stenosis, MBF
ncreases 5 times during hyperemia (stress testing), and
herefore the myocardium replenishes in 1 s. In addition, a
ow-limiting stenosis leads to a reduction in capillary blood
olume in the distal microvasculature, with an accompany-
ng decrease in signal intensity during MCE. These 2
eatures (slowed contrast appearance and decreased capillary
lood volume) form the basis for detecting CAD using
CE.
One of the first studies assessing MCE with triggered
igure 2. Example of adenosine stress myocardial contrast echocardiograph
pical 3-chamber view. (A) Baseline; (B) contrast destruction; (C to H) cmaging in stable CAD patients showed that MCE can Define the presence of abnormal perfusion at rest and
uring pharmacologic stress, with a high concordance
etween MCE and 99mTc-sestamibi single photon emis-
ion computerized tomography (SPECT) (17). Also,
omparison of accelerated intermittent imaging at rest
nd with exercise to 99mTc-sestamibi-SPECT demon-
trated a concordance of 76% to 92% (18). Several other
tudies assessed the accuracy of MCE and SPECT/
obutamine stress echocardiography (DSE) for detection
f stable CAD. In general, agreements are high, ranging
rom 65% to 92% (19 –27) (Table 1).
A number of these studies employed angiography as the
old standard (Table 2). Most reported a sensitivity of
CE for CAD detection that is similar to or higher than
PECT/DSE, ranging from 64% to 97%, compared with
3% to 100% for the latter (18,19,21,22,24,27–31). Fur-
hermore, the addition of MCE may improve sensitivity for
etection of CAD over wall motion analysis during DSE
18,29,31,32). We performed a meta-analysis of these
tudies and determined that the sensitivity and specificity of
CE for detection of CAD are at least not inferior to
PECT/DSE (Table 2, Fig. 5).
Myocardial contrast echocardiography also provides
rognostic value in patients with stable CAD (33). Patients
ith normal perfusion have a better outcome than patients
ith normal wall motion. This underscores the value of
ncorporating MCE in stress echocardiography. An exam-
le of a perfusion defect with real-time perfusion during
bsequent end-systolic frames) with region of interest for quantification the
st replenishment.SE is shown in Figure 6.
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Contrast Echocardiography for Perfusion Imaging December 5, 2006:2168–77CE IN ACUTE CORONARY SYNDROMES
urrently, the diagnosis of ACS is based on the triad of
linical history, electrocardiography, and laboratory investi-
ation. These methods, although useful, can often be
ondiagnostic in this setting. Because MCE is the only
echnique that permits immediate assessment of wall mo-
ion and perfusion, it has a unique role in the diagnosis of
CS. Myocardial contrast echocardiography allows quick
valuation of myocardial perfusion in the emergency depart-
ent and may be used to triage patients into a low- or
igh-risk category. The value of MCE in acute coronary
igure 3. Example of (A) replenishment curve with slope () and plateauigure 4. Parametric image of apical 4-chamber view, containing information a
yocardial blood flow, and (D) quality of data.yndromes has been studied experimentally using coro-
ary balloon occlusions in pigs. Myocardial contrast
chocardiography accurately reflects the decrease in myo-
ardial perfusion during balloon occlusion compared with
icrosphere-derived MBF (1). Studies have also shown that
uring coronary occlusion the area at risk correlates closely
ith the contrast defect early after contrast flash destruction
nd that the plateau contrast defect identifies infarct size
34). Kamp et al. (35) were the first to report the
ensitivity of MCE to detect perfusion defects in patients
uspected of having AMI. With 1:1 end-systolic–
(A) of the replenishment curve fitted to a monoexponential function (B).bout (A) peak intensity, (B) slope of replenishment curve, (C) estimate of
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December 5, 2006:2168–77 Contrast Echocardiography for Perfusion Imagingriggered imaging, MCE perfusion defects were detected
n 19 of 32 patients (59%) with Thrombolysis In Myo-
ardial Infarction (TIMI) flow grade 0 before percutane-
us transluminal coronary angioplasty (35). The sensitiv-
ty of MCE tended to decrease when patients had better
IMI flow and inferior infarctions (20%), whereas the
ensitivity of MCE in patients with an anterior coronary
rtery occlusion was high (88%). Other studies assessing
he potential of MCE to acute coronary syndromes also
eported high sensitivities, comparable with those of
tandard echocardiography and SPECT (35– 43) (Table
). In addition, MCE appears to have important prog-
igure 5. We conducted a meta-analysis of 8 studies (PubMed referenc
pecificity of myocardial contrast echocardiography (MCE) and single-ph
graphy (DSE) for detection of significant coronary artery disease (CAD)
ontrast echocardiography,” “single-photon emission computerized tomog
tudies were included when coronary angiography was used as gold standa
ochrane Collaboration Group was used to calculate variance-weighted p
etween MCE and SPECT/DSE according to a random effect meta-analys
95% confidence interval [CI] 0.09 to 0.20) and 0.03 (95% CI 0.14 to 0.2
o difference was found for the specificity. n/N number of patients with C
ith CAD; RD  risk difference. * indicates DSE.
igure 6. Example of dobutamine stress contrast echocardiography. Rever
erfusion defect during peak stress (arrows). Coronary angiography (angio) demo
eft circumflex (posteroapical defect), and right coronary arteries (inferoapical dostic value in patients presenting to the emergency
epartment with acute chest pain (38 – 43).
Besides detection of acute ischemic heart disease, MCE
ay play a pivotal role in prediction of functional recovery
n patients after ST-segment elevation myocardial infarc-
ion. The severity of myocardial damage is currently mainly
stimated by enzymatic damage and wall motion score,
hereas recovery of myocardial function is importantly
ependent on reflow of blood to the risk area. The presence
f reflow after coronary angioplasty is suggested by resolu-
ion of chest pain and the degree of resolution of ST-
egment elevation but can be visualized by MCE (Fig. 7).
s, restricted to English-language literature) assessing the sensitivity and
emission computed tomography (SPECT)/dobutamine stress echocardi-
ere published before January 2006. The text words used were “myocardial
,” “dobutamine stress echocardiography,” and “stress echocardiography.”
d if results were analyzed on a patient-based analysis. RevMan 4.2 of the
difference of proportions for the differences in sensitivity and specificity
e pooled estimates of the differences in sensitivity and specificity were 0.14
spectively, indicating a higher sensitivity for MCE than for SPECT/DSE.
detected by MCE or SPECT/DSE divided by the total number of patients
posterior/apical (apical 3-cv, A3C) and inferior/apical (apical 2-cv, A2C)e list
oton
that w
raphy
rd an
ooled
is. Th
1), re
ADsible
nstrates corresponding significant stenoses in the left anterior descending,
efect).
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Contrast Echocardiography for Perfusion Imaging December 5, 2006:2168–77loner (44) was the first to demonstrate the deleterious
ffect of no-reflow on clinical outcome. Later, it was shown
hat the presence of no-reflow on MCE after AMI related
o absence of pre-infarction angina, number of Q waves,
all motion score at presentation, TIMI flow grade 0, the
ize of the area at risk, and the occlusion status of the culprit
rtery (45). Conversely, intact microvasculature after AMI
reflow), is a positive predictor of functional recovery (46).
atients without microvascular dysfunction on MCE have
ess enzymatic elevation, better functional performance,
etter recovery of global and regional wall motion, less
emodeling, and better survival independent of other pre-
ictors (47–49). The ability of MCE to predict functional
ecovery is summarized in Table 4 (50–63) and is compa-
able to that of cardiovascular magnetic resonance imaging
64,65) (Fig. 8). Thus the existing literature suggests that
CE has important additional value for diagnosis and risk
tratification in patients with acute ischemic heart disease.
ARGETED IMAGING WITH ULTRASOUND CONTRAST
ecently, “targeted microbubbles” have been developed by
ncorporating ligands in the microbubble shell. Experimen-
al studies demonstrated that specific ligands to intercellular
dhesion molecule 1 (ICAM-1) and glycoprotein IIb/IIIa
nabled these targeted agents to bind selectively to ICAM-
–expressing tissue and thrombus, respectively (66,67).
igure 7. No-reflow after primary percutaneous transluminal coronary
able 3. Sensitivity and Specificity of MCE for Detection of Imp
Patients (n) ACS Type
amp et al. (35) 59 STEMI
occhi et al. (43) 30 AMI
oir et al. (36) 34 STEMI
agendorf et al. (42) 100 ACS
inter et al. (37) 35 ACS
ooled estimate 258
CC  American College of Cardiology; ACS  acute coronary syndrome; AHA
ontrast echocardiography; NA  not applicable; STEMI  ST-segment elevationu
ngioplasty for acute myocardial infarction (real-time myocardial contrast
chocardiography).ecause expression of ICAM-1 is associated with early
therosclerosis, targeted imaging could possibly play a role
n diagnosis of preclinical atherosclerosis. Imaging of
hrombus enables us to localize vascular clots in humans
oninvasively. Furthermore, lipid microbubbles with phos-
hatidylserine in the microbubble shell appear to attach to
nflamed tissue (68). Localized attachment of targeted
ltrasound contrast to specific tissue creates great opportu-
ities for development of new diagnostic tools and treat-
ent modalities (targeted drug delivery).
AFETY
he most important study assessing the safety of MCE was
erformed by Tsutsui et al. (69). More than 1,500 patients
nderwent dobutamine stress MCE with low-mechanical-
ndex real-time perfusion, during which no major adverse
vents were seen. Myocardial contrast echocardiography has
similar safety profile as dobutamine stress echocardiog-
aphy. In patients with heart failure, intravenous contrast
id not show any deleterious hemodynamic effects com-
ared with placebo (70). The occurrence of premature
entricular contractions, especially during end-systolic
igh-mechanical-index imaging, has been a matter of con-
ern. However, data regarding this aspect are conflicting,
nd, because significant arrhythmias during MCE are ob-
erved rarely, the clinical significance is doubtful (71).
RACTICAL ISSUES
yocardial contrast echocardiography is a relatively simple
echnique for imaging of myocardial perfusion. However,
here is a learning curve as with all noninvasive techniques.
ecause perfusion of the myocardium is assessed in 1
pecific region, it is important to keep the transducer still to
inimize movement of the heart. In contrast to real-time
maging, triggered imaging does not allow continuous
isualization of the heart (unless the system is equipped with
onitoring mode). Especially with this technique, the
uality of the images improves with more experience.
raining is also required for interpretation.
When performing MCE, infusion pump, blood pressure,
nd heart rate monitoring must be available. Stress testing
ith the stressors mentioned in the preceding is safe, and
he excellent safety profile is not expected to change when
Perfusion in Patients With Suspected ACS
Sensitivity Specificity Gold Standard
59% NA Angiography
84% 94% Angiography
79% 50% Angiography
84% 93% ACC/AHA guidelines
81% 67% Angiography
82% 63%
erican Heart Association; AMI  acute myocardial infarction; MCE  myocardial
rdial infarction.airedsed in contrast echocardiography. However, a physician
n
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December 5, 2006:2168–77 Contrast Echocardiography for Perfusion Imagingeeds to be present to monitor the well-being of the patient
72). Emergency medication and facilities should be present
n case of adverse events, which occur rarely.
UTURE PERSPECTIVES
eal-time 3-dimensional myocardial perfusion echocar-
iography. A promising tool within MCE is the develop-
ent of real-time 3-dimensional perfusion echocardiogra-
hy (73). The current matrix transducers use a more
omogeneous ultrasound field, which improves image qual-
ty, and acquire a full volume instead of 1 scanning plane.
mage interpretation is favored by slicing the myocardium in
he appropriate view, by which perfusion defects can be
isualized in any chosen myocardial region.
able 4. Prediction of Recovery of Regional and Global Function
yocardial Infarction
Regional Function
Patients
(n)
FU
(months) Sensitivit
olognese et al. (53) 30 1 96%
gati et al. (59)* 23 2 100%
winbum et al. (58)* 96 3–6 59%
ain et al. (60) 34 2 77%
illis et al. (55) 37 2 80%
anardhanan et al. (56) 50 3 87%
orosoglou et al. (57) 32 1 81%
uang et al. (63) 34 4 83%
unes Sbano et al. (61) 50 6 95%
be et al. (41) 21 6 98%
ooled estimate 407 81%
Global Function and Events
Patients
(n)
Reflow
EF Baseline EF FU
to et al. (51) 39 42  11 56  13
orter et al. (52) 45 59  10 63  9
akuma et al. (48) 50 44  9 56  12
olognese et al. (47) 124 40  7 51  11
ote: data are presented as percentage. *Patients partly revascularized.
EF  ejection fraction; FU  follow-up; NPV  negative predictive value; PPVigure 8. Fixed septal/apical perfusion defect (arrows) with myocardial contras
middle), and delayed enhancement with magnetic resonance imaging (right) aONCLUSIONS
n the past 10 years, MCE has developed from a research
ool to a clinically valuable technique in patients with
nown or suspected CAD. It is a rapid, safe, and accurate
ethod for imaging of myocardial perfusion and can be
sed for qualitative and quantitative assessment of MBF.
arge prospective multicenter trials would probably fa-
ilitate formal approval and more widespread acceptance
f MCE.
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Prediction of Events by MCE in Patients After Acute
Specificity PPV NPV Accuracy
18% 41% 89% 47%
90% 81% 100% 93%
76% 47% 84% UN
83% 90% 63% 79%
67% 66% 81% 73%
78% 65% 93% 81%
88% 95% 61% 83%
82% 92% 66% 83%
52% 55% 94% 68%
32% 43% 96% 55%
69% 64% 83% 74%
p No-Reflow Group
FU
(% Cardiac Death) EF Baseline EF FU
FU
(% Cardiac Death)
35  9 43  9
55  13 46  5
4% 35  18 45  14 12%
3% 33  8 NA 25%
sitive predictive value; UN  unknown.and
y
Grout echocardiography (left), single photon emission computed tomography
fter myocardial infarction.
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